What are the symptoms of malaria?
Malaria is a life-threatening parasitic infection transmitted primarily through the bite of an infected female Anopheles mosquito. Its clinical presentation varies depending on the Plasmodium species involved (most commonly P. falciparum, P. vivax, P. ovale, P. malariae, or the emerging P. knowlesi), the individual’s immune status, age, and access to timely treatment. Classic symptoms typically begin 10 days to 4 weeks after infection—though incubation may be longer with P. vivax or P. ovale due to dormant liver-stage hypnozoites—and often follow a cyclical pattern.
The hallmark of malaria is paroxysmal fever, which classically occurs in three distinct stages: a cold stage (chills and rigors), followed by a hot stage (high fever, headache, nausea, vomiting, and profound malaise), and concluding with a sweating stage (profuse diaphoresis and defervescence). These cycles may recur every 48 hours in P. vivax and P. ovale (tertian malaria) or every 72 hours in P. malariae (quartan malaria); however, P. falciparum infections frequently present with irregular, non-cyclical fevers and can rapidly progress to severe disease.
Other common manifestations include fatigue, myalgia, arthralgia, anorexia, and generalized weakness. Gastrointestinal symptoms such as abdominal pain, diarrhea, and jaundice (due to hemolysis and hepatic involvement) may also occur. In endemic areas, children and non-immune adults are at highest risk for complications—including cerebral malaria (characterized by altered mental status, seizures, or coma), severe anemia, acute kidney injury, acute respiratory distress syndrome (ARDS), hypoglycemia, metabolic acidosis, and multiorgan failure.
It is critical to recognize that asymptomatic or atypical presentations—especially in partially immune individuals or those taking prophylactic antimalarials—are not uncommon. Any unexplained fever in a person with recent travel to or residence in a malaria-endemic region warrants urgent evaluation, including thick and thin peripheral blood smears and/or rapid diagnostic testing (RDT). Early diagnosis and appropriate antimalarial therapy are essential to prevent progression to severe or fatal disease.